you will continue your examination of alternative exit strategies…

Question Answered step-by-step you will continue your examination of alternative exit strategies… you will continue your examination of alternative exit strategies that sometimes face companies in the merger process. Reorganizations in the form of Chapter 11 bankruptcy can place a company in the position of being protected from a takeover. However, sometimes that is not possible and a Chapter 7 liquidation is required which may involve the company being dissolved in the process. Finally, you will discuss how things may differ when the merger involves companies within different countries.After completing this unit, you should be able to:Examine differing reasons as to why corporations conduct cross-national transactions.Analyze indications a company may be poised for a downsizing or bankruptcy.Examine strategic options companies may take if failing.Discuss international market entry strategies.What exit strategy is the right one for your company? In this unit, you will be exposed to alternative strategies that you might employ if a merger or acquisition fails to complete. You will study bankruptcy reorganization and the liquidation of assets to satisfy creditors and customers. This unit also analyzes global mergers and acquisitions, and you will assess how to place value on and acquire cross-country companies.AC552-3: Assess the consequences of alternative corporate restructuring and reorganization techniques.Access the case study in your textbook, “AbbVie Places a Big Bet on Cancer Drug Maker Pharmacyclics” pp. 459-461. In this case, you will have an opportunity to evaluate AbbVie’s takeover of Pharmacyclics. The case illustrates how deals are structured.In addition to the requirements for the analysis of a case study covered below, please specifically answer the following questions:What is the form of payment used in this deal? Why might this form have been selected? What are the advantages and disadvantages of the form of payment used in this deal?What is the form of acquisition used in this deal? Why might this form have been chosen? What are the advantages and disadvantages of the form of acquisition?Would you characterize this as a reverse or forward merger? Based on your answer why might this type of reorganization have been selected by AbbVie?How would the fixed-value collar arrangement work to fix the value of the offer price? How would this affect AbbVie and Pharmacyclics shareholders?How would this deal be treated for financial-reporting purposes? Briefly describe how the methodology you have identified might be applied to how Pharmacyclics’ financial data would be presented on AbbVie’s consolidated financial statements.Assume it is determined by auditors during the next several years that AbbVie overpaid significantly for Pharmacyclics. What is the most likely reason this determination could happen? How might this impact the firm’s reported EPS and in turn its share price? Be specific.What is the purpose of a termination fee in these types of deals?Did the sale of Pharmacyclics require a vote by the firm’s shareholders? Please explain.  Business Accounting ACCOUNTING 552 Share QuestionEmailCopy link Comments (0)